Annual CAPEX
$2.24 M
-$3.37 M-60.07%
December 31, 2023
Summary
- As of February 26, 2025, CASI annual capital expenditures is $2.24 million, with the most recent change of -$3.37 million (-60.07%) on December 31, 2023.
- During the last 3 years, CASI annual CAPEX has fallen by -$17.09 million (-88.40%).
- CASI annual CAPEX is now -89.71% below its all-time high of $21.77 million, reached on December 31, 2018.
Performance
CASI CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 1, 2024
Summary
- CASI quarterly capital expenditures is not available.
Performance
CASI Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 1, 2024
Summary
- CASI TTM capital expenditures is not available.
Performance
CASI TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
CASI CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -60.1% | - | - |
3 y3 years | -88.4% | - | - |
5 y5 years | -89.7% | - | - |
CASI CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -85.5% | at low | ||||
5 y | 5-year | -88.4% | at low | ||||
alltime | all time | -89.7% | >+9999.0% |
CASI Pharmaceuticals CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $2.24 M(-60.1%) | - | - |
Dec 2022 | $5.61 M(-63.8%) | $3.43 M(+633.6%) | $5.61 M(-24.2%) |
Sep 2022 | - | $467.00 K(-182.1%) | $7.40 M(-24.2%) |
Jun 2022 | - | -$569.00 K(-124.9%) | $9.76 M(-13.7%) |
Mar 2022 | - | $2.29 M(-56.1%) | $11.31 M(-27.1%) |
Dec 2021 | $15.50 M(-19.8%) | $5.21 M(+84.5%) | $15.50 M(-11.8%) |
Sep 2021 | - | $2.83 M(+189.4%) | $17.57 M(-31.4%) |
Jun 2021 | - | $977.00 K(-84.9%) | $25.60 M(-0.8%) |
Mar 2021 | - | $6.48 M(-11.0%) | $25.81 M(+33.5%) |
Dec 2020 | $19.33 M(+37.9%) | $7.28 M(-33.0%) | $19.33 M(-2.5%) |
Sep 2020 | - | $10.86 M(+818.1%) | $19.83 M(+119.7%) |
Jun 2020 | - | $1.18 M(>+9900.0%) | $9.02 M(-34.5%) |
Mar 2020 | - | $1000.00(-100.0%) | $13.77 M(-1.8%) |
Dec 2019 | $14.02 M(-35.6%) | $7.78 M(>+9900.0%) | $14.02 M(+64.1%) |
Sep 2019 | - | $59.00 K(-99.0%) | $8.54 M(-0.9%) |
Jun 2019 | - | $5.93 M(+2252.4%) | $8.62 M(+164.2%) |
Mar 2019 | - | $252.00 K(-89.1%) | $3.26 M(-85.0%) |
Dec 2018 | $21.77 M(+2229.5%) | $2.30 M(+1597.9%) | $21.77 M(+8.9%) |
Sep 2018 | - | $135.70 K(-76.2%) | $20.00 M(-0.1%) |
Jun 2018 | - | $571.30 K(-97.0%) | $20.01 M(+1.8%) |
Mar 2018 | - | $18.76 M(+3447.6%) | $19.66 M(+2003.8%) |
Dec 2017 | $934.70 K(+318.8%) | $528.90 K(+255.0%) | $934.70 K(+99.0%) |
Sep 2017 | - | $149.00 K(-33.3%) | $469.80 K(+33.3%) |
Jun 2017 | - | $223.30 K(+566.6%) | $352.40 K(+82.6%) |
Mar 2017 | - | $33.50 K(-47.7%) | $193.00 K(-13.5%) |
Dec 2016 | $223.20 K(+778.7%) | $64.00 K(+102.5%) | $223.20 K(+38.7%) |
Sep 2016 | - | $31.60 K(-50.5%) | $160.90 K(+18.0%) |
Jun 2016 | - | $63.90 K(+0.3%) | $136.30 K(+54.7%) |
Mar 2016 | - | $63.70 K(+3647.1%) | $88.10 K(+245.5%) |
Dec 2015 | $25.40 K(-94.6%) | $1700.00(-75.7%) | $25.50 K(-63.8%) |
Sep 2015 | - | $7000.00(-55.4%) | $70.50 K(-76.6%) |
Jun 2015 | - | $15.70 K(+1327.3%) | $301.70 K(-29.1%) |
Mar 2015 | - | $1100.00(-97.6%) | $425.30 K(-8.8%) |
Dec 2014 | $466.30 K(+984.4%) | $46.70 K(-80.4%) | $466.30 K(+4.6%) |
Sep 2014 | - | $238.20 K(+71.0%) | $445.60 K(+114.9%) |
Jun 2014 | - | $139.30 K(+230.9%) | $207.40 K(+188.5%) |
Mar 2014 | - | $42.10 K(+61.9%) | $71.90 K(+67.6%) |
Dec 2013 | $43.00 K(-11.2%) | $26.00 K(>+9900.0%) | $42.90 K(-19.8%) |
Sep 2013 | - | $0.00(-100.0%) | $53.50 K(-18.1%) |
Jun 2013 | - | $3800.00(-71.0%) | $65.30 K(+6.2%) |
Mar 2013 | - | $13.10 K(-64.2%) | $61.50 K(+27.1%) |
Dec 2012 | $48.40 K(+706.7%) | $36.60 K(+210.2%) | $48.40 K(+310.2%) |
Sep 2012 | - | $11.80 K(>+9900.0%) | $11.80 K(+96.7%) |
Dec 2011 | $6000.00(+66.7%) | $0.00(-100.0%) | $6000.00(0.0%) |
Sep 2011 | - | $1800.00(>+9900.0%) | $6000.00(-1.6%) |
Jun 2011 | - | $0.00(-100.0%) | $6100.00(-21.8%) |
Mar 2011 | - | $4200.00(>+9900.0%) | $7800.00(+116.7%) |
Dec 2010 | $3600.00(+24.1%) | $0.00(-100.0%) | $3600.00(0.0%) |
Sep 2010 | - | $1900.00(+11.8%) | $3600.00(+111.8%) |
Jun 2010 | - | $1700.00(>+9900.0%) | $1700.00(-98.7%) |
Dec 2009 | $2900.00(-97.8%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2008 | $134.10 K(+25.7%) | $0.00(-100.0%) | $134.10 K(-27.7%) |
Sep 2008 | - | $17.20 K(-22.5%) | $185.50 K(-2.0%) |
Jun 2008 | - | $22.20 K(-76.6%) | $189.30 K(+0.9%) |
Mar 2008 | - | $94.70 K(+84.2%) | $187.60 K(+75.8%) |
Dec 2007 | $106.70 K(-53.1%) | $51.40 K(+144.8%) | $106.70 K(-25.6%) |
Sep 2007 | - | $21.00 K(+2.4%) | $143.50 K(-29.4%) |
Jun 2007 | - | $20.50 K(+48.6%) | $203.40 K(-2.5%) |
Mar 2007 | - | $13.80 K(-84.4%) | $208.60 K(-8.3%) |
Dec 2006 | $227.40 K(-8.6%) | $88.20 K(+9.0%) | $227.40 K(+3.3%) |
Sep 2006 | - | $80.90 K(+214.8%) | $220.10 K(+29.4%) |
Jun 2006 | - | $25.70 K(-21.2%) | $170.10 K(-38.6%) |
Mar 2006 | - | $32.60 K(-59.7%) | $276.90 K(+11.3%) |
Dec 2005 | $248.70 K(+52.1%) | $80.90 K(+161.8%) | $248.80 K(+32.7%) |
Sep 2005 | - | $30.90 K(-76.7%) | $187.50 K(+5.9%) |
Jun 2005 | - | $132.50 K(+2844.4%) | $177.00 K(+137.3%) |
Mar 2005 | - | $4500.00(-77.0%) | $74.60 K(-54.4%) |
Dec 2004 | $163.50 K(+400.0%) | $19.60 K(-3.9%) | $163.50 K(+8.9%) |
Sep 2004 | - | $20.40 K(-32.2%) | $150.10 K(+13.4%) |
Jun 2004 | - | $30.10 K(-67.8%) | $132.40 K(+9.0%) |
Mar 2004 | - | $93.40 K(+1406.5%) | $121.50 K(+271.6%) |
Dec 2003 | $32.70 K(-94.1%) | $6200.00(+129.6%) | $32.70 K(-80.7%) |
Sep 2003 | - | $2700.00(-85.9%) | $169.20 K(-20.5%) |
Jun 2003 | - | $19.20 K(+317.4%) | $212.80 K(-40.2%) |
Mar 2003 | - | $4600.00(-96.8%) | $356.00 K(-36.2%) |
Dec 2002 | $558.20 K(-43.4%) | $142.70 K(+208.2%) | $558.30 K(-6.7%) |
Sep 2002 | - | $46.30 K(-71.5%) | $598.60 K(-14.0%) |
Jun 2002 | - | $162.40 K(-21.5%) | $696.10 K(-27.4%) |
Mar 2002 | - | $206.90 K(+13.1%) | $959.00 K(-2.7%) |
Dec 2001 | $985.80 K(-39.9%) | $183.00 K(+27.3%) | $985.80 K(-15.3%) |
Sep 2001 | - | $143.80 K(-66.2%) | $1.16 M(-34.9%) |
Jun 2001 | - | $425.30 K(+82.0%) | $1.79 M(+9.0%) |
Mar 2001 | - | $233.70 K(-35.3%) | $1.64 M(-0.0%) |
Dec 2000 | $1.64 M(-13.7%) | $361.40 K(-52.9%) | $1.64 M(+10.9%) |
Sep 2000 | - | $766.80 K(+176.2%) | $1.48 M(+88.1%) |
Jun 2000 | - | $277.60 K(+18.4%) | $786.10 K(-34.6%) |
Mar 2000 | - | $234.50 K(+17.3%) | $1.20 M(-36.8%) |
Dec 1999 | $1.90 M(+5.6%) | $200.00 K(+170.3%) | $1.90 M(-32.1%) |
Sep 1999 | - | $74.00 K(-89.3%) | $2.80 M(-10.4%) |
Jun 1999 | - | $692.90 K(-25.7%) | $3.13 M(+18.7%) |
Mar 1999 | - | $933.10 K(-15.2%) | $2.63 M(+46.3%) |
Dec 1998 | $1.80 M(+80.0%) | $1.10 M(+175.0%) | $1.80 M(+5.9%) |
Sep 1998 | - | $400.00 K(+100.0%) | $1.70 M(+88.9%) |
Jun 1998 | - | $200.00 K(+100.0%) | $900.00 K(-10.0%) |
Mar 1998 | - | $100.00 K(-90.0%) | $1.00 M(0.0%) |
Dec 1997 | $1.00 M(+400.0%) | $1.00 M(-350.0%) | $1.00 M(>+9900.0%) |
Sep 1997 | - | -$400.00 K(-233.3%) | $0.00(-100.0%) |
Jun 1997 | - | $300.00 K(+200.0%) | $500.00 K(+66.7%) |
Mar 1997 | - | $100.00 K(>+9900.0%) | $300.00 K(+50.0%) |
Dec 1996 | $200.00 K | $0.00(-100.0%) | $200.00 K(0.0%) |
Sep 1996 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
Jun 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is CASI Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for CASI Pharmaceuticals?
- What is the all time high TTM CAPEX for CASI Pharmaceuticals?
What is CASI Pharmaceuticals annual capital expenditures?
The current annual CAPEX of CASI is $2.24 M
What is the all time high annual CAPEX for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual capital expenditures is $21.77 M
What is CASI Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, CASI annual capital expenditures has changed by -$3.37 M (-60.07%)
What is the all time high quarterly CAPEX for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly capital expenditures is $18.76 M
What is the all time high TTM CAPEX for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high TTM capital expenditures is $25.81 M